Tweet
Infect Chemother
. 2025 Apr 30.
doi: 10.3947/ic.2025.0033. Online ahead of print. Recommendations for Influenza Vaccination in Immunocompromised Patients
Joon Young Song 1 , Ki Tae Kwon 2 , Wan Beom Park 3 , Ji Yun Noh 4 , Sun Hee Park 5 , Eun Ju Choo 6 , Min Joo Choi 4 , Jun Yong Choi 7 , Jung Yeon Heo 8 , Won Suk Choi 4 ; Committee of Adult Immunization in the Korean Society of Infectious Diseases
Affiliations
Annual influenza vaccination is strongly recommended for immunocompromised individuals, who are at a higher risk of severe infection. The Korean Society of Infectious Diseases has revised its influenza vaccination recommendations for solid organ transplant recipients, advocating for the use of highly immunogenic vaccines, such as high-dose inactivated influenza vaccines or MF59-adjuvanted inactivated influenza vaccines, to enhance vaccine efficacy. While further research is needed to extend these recommendations to other immunocompromised populations, these vaccines have demonstrated improved immunogenicity without compromising safety. Expanding vaccination guidelines to additional immunocompromised groups should be considered as more evidence emerges.
Keywords: Immunocompromised host; Influenza; Vaccination.
. 2025 Apr 30.
doi: 10.3947/ic.2025.0033. Online ahead of print. Recommendations for Influenza Vaccination in Immunocompromised Patients
Joon Young Song 1 , Ki Tae Kwon 2 , Wan Beom Park 3 , Ji Yun Noh 4 , Sun Hee Park 5 , Eun Ju Choo 6 , Min Joo Choi 4 , Jun Yong Choi 7 , Jung Yeon Heo 8 , Won Suk Choi 4 ; Committee of Adult Immunization in the Korean Society of Infectious Diseases
Affiliations
- PMID: 40490381
- DOI: 10.3947/ic.2025.0033
Annual influenza vaccination is strongly recommended for immunocompromised individuals, who are at a higher risk of severe infection. The Korean Society of Infectious Diseases has revised its influenza vaccination recommendations for solid organ transplant recipients, advocating for the use of highly immunogenic vaccines, such as high-dose inactivated influenza vaccines or MF59-adjuvanted inactivated influenza vaccines, to enhance vaccine efficacy. While further research is needed to extend these recommendations to other immunocompromised populations, these vaccines have demonstrated improved immunogenicity without compromising safety. Expanding vaccination guidelines to additional immunocompromised groups should be considered as more evidence emerges.
Keywords: Immunocompromised host; Influenza; Vaccination.